Imaging minimal residual disease evaluation in multiple myeloma using [18F]FDG PET/MRI

Leuk Lymphoma. 2023 Feb;64(2):503-506. doi: 10.1080/10428194.2022.2142053. Epub 2022 Nov 16.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Fluorodeoxyglucose F18*
  • Humans
  • Magnetic Resonance Imaging / methods
  • Multiple Myeloma* / diagnostic imaging
  • Neoplasm, Residual
  • Positron Emission Tomography Computed Tomography / methods
  • Positron-Emission Tomography / methods
  • Radiopharmaceuticals

Substances

  • Fluorodeoxyglucose F18
  • Radiopharmaceuticals